The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management.
ARDS
SARS-CoV-19
high resolution computed tomography
interstitial pneumonia
lung ultrasound
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
31 Jul 2022
31 Jul 2022
Historique:
received:
03
07
2022
revised:
24
07
2022
accepted:
27
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Purpose: We aimed to assess the role of lung ultrasound (LUS) in the diagnosis and prognosis of SARS-CoV-2 pneumonia, by comparing it with High Resolution Computed Tomography (HRCT). Patients and methods: All consecutive patients with laboratory-confirmed SARS-CoV-2 infection and hospitalized in COVID Centers were enrolled. LUS and HRCT were carried out on all patients by expert operators within 48−72 h of admission. A four-level scoring system computed in 12 regions of the chest was used to categorize the ultrasound imaging, from 0 (absence of visible alterations with ultrasound) to 3 (large consolidation and cobbled pleural line). Likewise, a semi-quantitative scoring system was used for HRCT to estimate pulmonary involvement, from 0 (no involvement) to 5 (>75% involvement for each lobe). The total CT score was the sum of the individual lobar scores and ranged from 0 to 25. LUS scans were evaluated according to a dedicated scoring system. CT scans were assessed for typical findings of COVID-19 pneumonia (bilateral, multi-lobar lung infiltration, posterior peripheral ground glass opacities). Oxygen requirement and mortality were also recorded. Results: Ninety-nine patients were included in the study (male 68.7%, median age 71). 40.4% of patients required a Venturi mask and 25.3% required non-invasive ventilation (C-PAP/Bi-level). The overall mortality rate was 21.2% (median hospitalization 30 days). The median ultrasound thoracic score was 28 (IQR 20−36). For the CT evaluation, the mean score was 12.63 (SD 5.72), with most of the patients having LUS scores of 2 (59.6%). The bivariate correlation analysis displayed statistically significant and high positive correlations between both the CT and composite LUS scores and ventilation, lactates, COVID-19 phenotype, tachycardia, dyspnea, and mortality. Moreover, the most relevant and clinically important inverse proportionality in terms of P/F, i.e., a decrease in P/F levels, was indicative of higher LUS/CT scores. Inverse proportionality P/F levels and LUS and TC scores were evaluated by univariate analysis, with a P/F−TC score correlation coefficient of −0.762, p < 0.001, and a P/F−LUS score correlation coefficient of −0.689, p < 0.001. Conclusions: LUS and HRCT show a synergistic role in the diagnosis and disease severity evaluation of COVID-19.
Identifiants
pubmed: 36010207
pii: diagnostics12081856
doi: 10.3390/diagnostics12081856
pmc: PMC9406504
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Ultrasound Med. 2020 Jul;39(7):1413-1419
pubmed: 32227492
Respirology. 2020 May;25(5):535-542
pubmed: 31373748
Intensive Care Med. 2019 Sep;45(9):1200-1211
pubmed: 31418060
Crit Care Med. 2010 Jan;38(1):84-92
pubmed: 19633538
Radiology. 2020 Jun;295(3):200463
pubmed: 32077789
Radiology. 2020 Sep;296(3):E186-E188
pubmed: 32324103
Emerg Med Australas. 2020 Oct;32(5):883-889
pubmed: 32578933
Intensive Care Med. 2021 Nov;47(11):1329-1331
pubmed: 34595567
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4059-4061
pubmed: 32374009
Eur Rev Med Pharmacol Sci. 2021 May;25(9):3623-3631
pubmed: 34002839
Diagnostics (Basel). 2022 Mar 29;12(4):
pubmed: 35453889
Ann Emerg Med. 2021 Apr;77(4):385-394
pubmed: 33461884
Eur J Radiol. 2020 Sep;130:109202
pubmed: 32745895
Diagnostics (Basel). 2022 Jan 16;12(1):
pubmed: 35054382
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
PLoS One. 2021 Aug 25;16(8):e0256359
pubmed: 34432835
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
Front Immunol. 2022 Mar 24;13:835104
pubmed: 35401519
Anesthesiology. 2021 Jun 1;134(6):949-965
pubmed: 33819339
J Ultrasound Med. 2020 Jul;39(7):1459-1462
pubmed: 32198775
BMC Anesthesiol. 2021 Jun 28;21(1):178
pubmed: 34182946
Diagnostics (Basel). 2021 Dec 07;11(12):
pubmed: 34943531
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Clin Med. 2022 Mar 19;11(6):
pubmed: 35330029
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33231615
Proc (Bayl Univ Med Cent). 2020 Oct 26;34(1):1-4
pubmed: 33446945
Respiration. 2014;88(6):458-68
pubmed: 25376260
Eur Respir Rev. 2021 Oct 20;30(162):
pubmed: 34670808
Ultrasound Med Biol. 2020 Nov;46(11):2938-2944
pubmed: 32828577
Infect Dis Ther. 2020 Dec;9(4):1029-1041
pubmed: 33067768
J Ultrasound Med. 2021 Aug;40(8):1627-1635
pubmed: 33155689
Eur Radiol. 2021 Feb;31(2):1059-1068
pubmed: 32852587
Radiology. 2020 Sep;296(3):E189-E191
pubmed: 32324102
J Clin Med. 2021 Jul 23;10(15):
pubmed: 34362039
Intensive Care Med. 2013 Jan;39(1):74-84
pubmed: 23052950
Diagnostics (Basel). 2022 Mar 30;12(4):
pubmed: 35453906
Life Sci. 2020 Aug 1;254:117788
pubmed: 32475810
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2776-2780
pubmed: 32196627
Eur Clin Respir J. 2021 Apr 7;8(1):1909521
pubmed: 33889342
BMJ Open. 2020 Sep 25;10(9):e040729
pubmed: 32978207
Arthritis Res Ther. 2011 Aug 18;13(4):R134
pubmed: 21851634
J Ultrasound Med. 2022 Jun;41(6):1367-1375
pubmed: 34468039
Radiology. 2020 Dec;297(3):E335-E338
pubmed: 32407256
Clin Rheumatol. 2012 Nov;31(11):1537-41
pubmed: 22843171
Expert Rev Respir Med. 2019 Feb;13(2):163-172
pubmed: 30616416
Diagnostics (Basel). 2021 Jul 27;11(8):
pubmed: 34441286
Ann Surg. 2020 Dec;272(6):919-924
pubmed: 33021367
IEEE Trans Ultrason Ferroelectr Freq Control. 2020 Mar;67(3):612-623
pubmed: 31670665
Intensive Care Med. 2020 Oct;46(10):1873-1883
pubmed: 32860069
J Ultrasound Med. 2022 Apr 15;:
pubmed: 35429016
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930